United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

bi-coastal pharma international llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

twi pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 40 mg in 1 g - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

twi pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% time release cream is indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration (such as chloasma, melasma, freckles, and senile lentigines) resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or on children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

ambi enterprises llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - - for the gradual fading of dark (brownish) discolorations in the skin such as freckles, age and liver spots, pigment in the skin that may occur in pregnancy or from the use of oral contraceptives  - contains a sunscreen to help prevent darkening from reoccurring

United States - English - NLM (National Library of Medicine)

ambi enterprises llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - - for the gradual fading of dark (brownish) discolorations in the skin such as freckles, age and liver spots, pigment in the skin that may occur in pregnancy or from the use of oral contraceptives  - contains a sunscreen to help prevent darkening from reoccurring

United States - English - NLM (National Library of Medicine)

zo skin health, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 0.04 g in 1 g - for the gradual bleaching of hyperpigmented skin conditions such as cholasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any other ingredient in this product. the safety of topical hydroquinone use during pregnancy or in children (21 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.

United States - English - NLM (National Library of Medicine)

the skin atelier, inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 0.04 g in 1 g - gently smooth over entire face. let product absorb at least 2 minutes before applying lotion. this lightening treatment lightens the skin with minimal irritation. brightens sun damage, melasma and dark spots on skin. this lightening treatment lightens skin with minimal irritation. brightens sun damage, melasma and dark spots on skin.

United States - English - NLM (National Library of Medicine)

syntenza pharmaceuticals llc - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone usp, 4% skin bleaching cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. the safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.